• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

DBU conference call

anonymous

Guest
DN can suck a big fat one. I can't believe the first 20 min of the conference call was all political. What a waste of time. Grow up and go preach your political views somewhere else.